AKT1 and cancer: Taken together, our findings demonstrated that Aur-A stimulated NF-κB signaling pathway via Akt activation to promote cancer cell survival, and formed a conceptual basis for the combination chemotherapy of targeting both Aurora kinase and growth factor-induced PI3K pathway for inhibiting the enhanced survival and migration of cancer cells.